Cazzaniga L F, Bossi A, Cosentino D, Frigerio M, Martinelli A, Monti A, Morresi A, Ostinelli A, Scandolaro L, Valli M C, Besana G
Department of Radiotherapy, Azienda Ospedaliera S. Anna, Como, Italy.
Radiat Oncol Investig. 1998;6(1):58-62. doi: 10.1002/(SICI)1520-6823(1998)6:1<58::AID-ROI7>3.0.CO;2-H.
Acute pneumonitis following breast irradiation is a rare and transient phenomenon that can be easily managed by drugs. The aim of this study is to evaluate late sequelae on lung, after postoperative radiotherapy (RT) for breast cancer. We were concerned with investigating late radiological findings when very small lung volumes are involved in the irradiated volume. We studied 28 consecutive patients. They underwent clinical examination and all staging procedures before surgery, evaluation of pulmonary function with spirometry, postoperative chest x-ray and high resolution computed tomography (HRCT) of the lung before RT. Clinical examinations were usually performed every 3 months after RT. A second chest x-ray, HRCT and spirometry were carried out after nearly 7 months from the end of RT. We estimated the irradiated lung volume by measuring the area of the lung surface enclosed by the 50% isodose (LA50) in each profile. We found a significant correlation between LA50 and the score of radiological findings after RT. No correlations were found between other factors (i.e., adjuvant chemotherapy, age, weight, smoking) and lung fibrosis. No woman developed radiation pneumonitis syndrome or respiratory symptoms. Our results indicate that irradiation of the breast and/or chest wall is well tolerated if treatment planning is done accurately. The fibrosis likelihood is strongly correlated to the irradiated lung volume. The use of tangential fields limits radiological changes that can be detected only by HRCT examination and are not associated with clinical symptoms.
乳腺癌放疗后发生的急性肺炎是一种罕见的短暂现象,可用药物轻松处理。本研究的目的是评估乳腺癌术后放疗(RT)对肺部的晚期后遗症。我们关注的是当照射野涉及非常小的肺容积时的晚期放射学表现。我们研究了连续28例患者。他们在手术前接受了临床检查和所有分期程序,通过肺活量测定法评估肺功能,放疗前进行了术后胸部X线检查和肺部高分辨率计算机断层扫描(HRCT)。放疗后通常每3个月进行一次临床检查。放疗结束近7个月后进行了第二次胸部X线检查、HRCT和肺活量测定。我们通过测量每个层面中50%等剂量线(LA50)所包围的肺表面面积来估计受照射的肺容积。我们发现LA50与放疗后放射学表现评分之间存在显著相关性。未发现其他因素(即辅助化疗、年龄、体重、吸烟)与肺纤维化之间存在相关性。没有女性发生放射性肺炎综合征或呼吸道症状。我们的结果表明,如果精确进行治疗计划,乳房和/或胸壁放疗耐受性良好。纤维化可能性与受照射的肺容积密切相关。使用切线野限制了仅通过HRCT检查才能检测到且与临床症状无关的放射学变化。